A 2,5-Diketopiperazine (2,5-DKP) is a type of cyclic organic compound that results from peptide bonds between two amino acids to form a double lactam. They are the smallest cyclic peptides. In keeping with standard IUPAC organic nomenclature, the "2,5-" designates the atoms on the diketopiperazine ring that are the carbonyls.
The parent compound is 2,5-diketopiperazine, the cyclic compound derived from dehydration of the dipeptide glycylglycine. It was the first peptide to have its complete three-dimensional structure described, in work undertaken Robert Corey in the 1930s.
2,5-Diketopiperazines are commonly biosynthesized from amino acids by a variety of organisms, including mammals, and are considered to be secondary metabolites. Some proteases, such as dipeptidyl peptidases, cleave the terminal ends of proteins to generate dipeptides, which naturally cyclize to form 2,5-diketopiperazines.
Drug design scaffold
Due to their rigidity, chirality (except for the glycylglycine derivative), and varied side chains, 2,5-diketopiperazines are an attractive scaffolds for drug design. Both natural and synthetic 2,5-diketopiperazines exhibit a variety of biological activities including antitumor, antiviral, antifungal and antibacterial activities.
The diketopiperazine obtains from glycylserine is a reagent for the preparation of C-alkylated derivatives of glycine. This approach is useful for the production of unnatural amino acids with stereochemical control. The diketopiperazine skeleton protects both the N and O termini of the glycine. For this application, the diketopiperazine is O-alkylated with concomitant N-deprotonation to give what is called the Schöllkopf reagent.
|Wikimedia Commons has media related to 2,5-Diketopiperazines.|
- Corey, R. B. (1938). "Crystal Structure of Diketopiperazine". Journal of the American Chemical Society 60 (7): 1598–1604. doi:10.1021/ja01274a023.
- Martins, M. B.; Carvalho, I. (2007). "Diketopiperazines: Biological Activity and Synthesis". Tetrahedron 63 (40): 9923–9932. doi:10.1016/j.tet.2007.04.105.
- Nicholson, B.; Lloyd, G. K.; Miller, B. R.; Palladino, M. A.; Kiso, Y.; Hayashi, Y.; Neuteboom, S. T. (2006). "NPI-2358 is a Tubulin-depolymerizing Agent: In-vitro Evidence for Activity as a Tumor Vascular-Disrupting Agent". Anti-Cancer Drugs 17 (1): 25–31. doi:10.1097/01.cad.0000182745.01612.8a. PMID 16317287.
- Sinha, S.; Srivastava, R.; de Clercq, E.; Singh, R. K. (2004). "Synthesis and Antiviral Properties of Arabino and Ribonucleosides of 1,3-Dideazaadenine, 4-Nitro-1,3-dideazapurine and Diketopiperazine". Nucleosides, Nucleotides and Nucleic Acids 23 (12): 1815–1824. doi:10.1081/NCN-200040614. PMID 15628741.
- Houston, D. R.; Synstad, B.; Eijsink, V. G.; Stark, M. J.; Eggleston, I. M.; van Aalten, D. M. (2004). "Structure-Based Exploration of Cyclic Dipeptide Chitinase Inhibitors". Journal of Medicinal Chemistry 47 (23): 5713–5720. doi:10.1021/jm049940a. PMID 15509170.
- Kwon, O. S.; Park, S. H.; Yun, B.-S.; Pyun, Y. R.; Kim, C.-J. (2000). "Cyclo(Dehydroala-L-Leu), an α-Glucosidase Inhibitor from Penicillium sp. F70614" (pdf). Journal of Antibiotics 53 (9): 954–958. doi:10.7164/antibiotics.53.954. PMID 11099229.
- Thomas Wirth "New Strategies to α-Alkylated α-Amino Acids" Angewandte Chemie International Edition in English 1997, Volume 36, Issue 3, pages 225–227. doi:10.1002/anie.199702251